跳至主要内容
临床试验/CTRI/2025/08/093833
CTRI/2025/08/093833尚未招募Unknown

A Single Blind Clinical Study to evaluate the Eye Stinging Potential of Purite Baby 3 in 1 TF010625 on healthy human volunteers

Marico South East Asia Corporation1 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2025年9月10日

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
32
试验地点
1
主要终点
1. Change in Discomfort

研究概览

简要总结

In Visit 1/Day 0 

Step 1: Firstly, the subject enrolls into the study as per inclusion and exclusion criteria

Step 2: Assessment of the subject as per discussed above (refer to study design)

In Visit 2/ Day 1 To check the irritation potential of the Purite Baby 3 in 1 TF010625

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • 1.Healthy males or females, 18 to 65 years with no medical conditions of the eyes as determined by the subjects medical history and confirmed by an ophthalmologist
  • Subjects not under any doctor care for ocular or peri orbital diseases
  • The subject will refrain from using contact lenses, any topical facial products, any eye drops, false eyelashes, make up, over the counter products, or cosmetics on their eyes, eyelids, eyelashes, or the periorbital areas of the face during the study.

排除标准

  • 1.Subjects who are pregnant, breast-feeding, or planning to become pregnant during the study.
  • 2.Have any evidence of systemic cancer, squamous cell carcinoma, basal cell carcinoma, in the last 5 years, or any other confounding skin condition.
  • 3.Have any condition that, in the opinion of the investigator, would confound the safety and/or efficacy assessments of the product.
  • 4.Have participated in any interventional clinical trial in the previous 30 days.
  • 5.Have a known sensitivity to any of the constituents of the test product including sensitivities to cocoamidopropyl betaine, coumarin, Aloe barbadensis etc.
  • 6.Have used, are using, or are planning to use immunosuppressive or immunomodulatory medication (i.e., biologics), including corticosteroids.
  • 7.Have a history of alcohol or illegal drug/substance abuse, or suspected alcohol or illegal drug/substance abuse in the past 2 years.

结局指标

主要结局

1. Change in Discomfort

时间窗: Time Points t1min, t2min, t5min

2. Change in Lacrimation

时间窗: Time Points t1min, t2min, t5min

3. Change in Conjunctival inflammation

时间窗: Time Points t1min, t2min, t5min

4. Change in Cornea and iris inflammation

时间窗: Time Points t1min, t2min, t5min

次要结局

  • Not Applicable(Not Applicable)

研究者

发起方
Marico South East Asia Corporation
申办方类型
Pharmaceutical industry-Global
责任方
Principal Investigator
主要研究者

Dr Ishika Gandhi

CCFT Laboratories

研究点 (1)

Loading locations...

相似试验